+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Use of 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil as a novel antiviral agent for hepatitis B virus and Epstein-Barr virus



Use of 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil as a novel antiviral agent for hepatitis B virus and Epstein-Barr virus



Antimicrobial Agents and ChemoTherapy 39(4): 979-981



A novel anti-hepatitis B virus (anti-HBV) agent, 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil (L-FMAU), was synthesized and found to be a potent anti-HBV and anti-Epstein-Barr virus agent. Its in vitro potency was evaluated in 2.2.15 and H1 cells for anti-HBV and anti-Epstein-Barr virus activities, respectively. In vitro cytotoxicity in MT2, CEM, 2.2.15, and H1 cells was also assessed, and the results indicated high antiviral selectivities of L-FMAU in these cells.

(PDF emailed within 0-6 h: $19.90)

Accession: 009702294

Download citation: RISBibTeXText

PMID: 7786007

DOI: 10.1128/AAC.39.4.979


Related references

Inhibition of Epstein-Barr virus replication by a novel L-nucleoside, 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil. Biochemical Pharmacology 51(7): 941-947, 1996

Effect of e 5 2 bromovinyl 1 beta d arabinofuranosyluracil and 5 vinyl 1 beta d arabinofuranosyluracil on epstein barr virus antigen expression in p3hr 1 cells comparison with acyclovir. Acta Virologica 31(1): 13-18, 1987

In vitro susceptibilities of wild-type or drug-resistant hepatitis B virus to (-)-beta-D-2,6-diaminopurine dioxolane and 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil. Antimicrobial Agents and ChemoTherapy 45(9): 2495-2501, 2001

Preclinical pharmacology and pharmacokinetics of the anti-hepatitis virus agent 2'-fluoro-5-ethyl-1-beta-D-arabinofuranosyluracil in mice and rats. Antimicrobial Agents and ChemoTherapy 36(7): 1472-1477, 1992

Mutations of the woodchuck hepatitis virus polymerase gene that confer resistance to lamivudine and 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil. Journal of Virology 76(3): 1213-1223, 2002

2-Fluoro-5-methyl-beta-L-arabinofuranosyluracil, a novel L-nucleoside analog, inhibits duck hepatitis B virus replication in primary hepatocytes and in vivo. Antiviral Research 30(1): A24, 1996

Nucleosides 146. 1 methyl 5 2 deoxy 2 fluoro beta d arabinofuranosyluracil the c nucleoside isostere of the potent antiviral agent 1 2 deoxy 2 fluoro beta d arabinofuranosylthymine fmau studies directed toward the synthesis of 2' deoxy 2' substituted arabinonucleosides 6. Journal of Medicinal Chemistry 30(12): 2314-2316, 1987

Relationship between the amounts of epstein barr virus dna and epstein barr virus nuclear antigen per cell clonability and tumorigenicity in 2 epstein barr virus negative lymphoma lines and their epstein barr virus converted sublines. International Journal of Cancer 31(2): 163-170, 1983

Molecular size variation of epstein barr virus induced nuclear antigen is determined by the epstein barr viral genome studies on sublines of epstein barr virus negative lymphomas converted with different epstein barr virus substrains and on somatic hybrids. Intervirology 22(2): 85-96, 1984

Mutations of the woodchuck hepatitis virus polymerase gene that confer resistance to lamivudine and 2'-fluoro-5-methyl-b- L-arabinofuranosyluracil. Journal of Virology 76(3): 13-23, 2002

Effect of (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil on Epstein-Barr virus antigen expression in P3HR-1 cells: comparison with acyclovir. Acta Virologica 31(1): 13-18, 1987

Antiviral activity of various 1-(2'-deoxy-β-D-lyxofuranosyl), 1-(2'-fluoro-β-D-xylofuranosyl), 1-(3'-fluoro-β-D-arabinofuranosyl), and 2'-fluoro-2',3'-didehydro-2',3'-dideoxyribose pyrimidine nucleoside analogues against duck hepatitis B virus (DHBV) and human hepatitis B virus (HBV) replication. Journal of Medicinal Chemistry 53(19): 7156-7166, 2010

Infection of mouse lymphocytes by epstein barr virus 2 stimulation of cellular dna synthesis by epstein barr virus in the absence of epstein barr virus determined nuclear antigen induction and cell transformation. 1984

Establishment of epstein barr virus nuclear antigen expressing cell lines by infection of epstein barr virus genome negative human lymphoma cells with different epstein barr virus strains. International Journal Of Cancer: 161-166, 1976

Epstein barr virus lymphoid cell interactions 2. the influence of epstein barr virus replication cycle on natural killing and antibody dependent cellular cyto toxicity against epstein barr virus infected cells. Clinical and Experimental Immunology 48(3): 589-601, 1982